PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,734 | -32.4% | 168,921 | -8.0% | 0.00% | – |
| Q2 2023 | $525,044 | -74.3% | 183,582 | -73.8% | 0.00% | – |
| Q1 2023 | $2,041,220 | +6.4% | 701,450 | +7.2% | 0.00% | – |
| Q4 2022 | $1,917,735 | +24.2% | 654,517 | +1.8% | 0.00% | – |
| Q3 2022 | $1,544,000 | +7.3% | 643,174 | +0.1% | 0.00% | – |
| Q2 2022 | $1,439,000 | +1.8% | 642,374 | +4.5% | 0.00% | – |
| Q1 2022 | $1,414,000 | -7.8% | 614,625 | +0.2% | 0.00% | – |
| Q4 2021 | $1,534,000 | – | 613,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 153,130 | $352,000 | 0.46% |
| SABBY MANAGEMENT, LLC | 1,275,468 | $2,934,000 | 0.44% |
| Shay Capital LLC | 944,666 | $2,173,000 | 0.28% |
| EQUITEC PROPRIETARY MARKETS, LLC | 309,294 | $711,000 | 0.16% |
| FNY Investment Advisers, LLC | 59,066 | $135,000 | 0.13% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 34,805 | $80,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 26,300 | $60,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 213 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 58 | $0 | 0.00% |